What is Oraceutical?
Oraceutical operates at the forefront of oral care innovation, specializing in the research, development, and licensing of proprietary technologies for both human and companion-animal markets. The company's expertise extends to product development, specialized manufacturing processes including high-viscosity product filling, and comprehensive analytical services. These services encompass product improvement, stability testing, and crucial regulatory guidance, positioning Oraceutical as a comprehensive solutions provider for clients in the consumer and dental industries seeking cutting-edge oral care products.
How much funding has Oraceutical raised?
Oraceutical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Oraceutical?
The substantial late-stage funding indicates Oraceutical is poised for significant scaling and market penetration. This capital infusion is expected to accelerate product commercialization, expand manufacturing capabilities, and potentially fuel further research into novel oral care applications. The strategic nature of the recent investment suggests a strong alignment with Oraceutical's long-term vision, likely enabling key partnerships and market expansion initiatives to solidify its leadership in the oral care technology landscape.
See full Oraceutical company page
